Thromb Haemost 1960; 4(03): 424-434
DOI: 10.1055/s-0038-1654525
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Viscous Metamorphosis Produced by Chilling and by Clotting Failure to Find Specific Defect of Viscous Metamorphosis in PTA Syndrome[*]

Marjorie B. Zucker
1   Clotting Mechanisms Section, Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research, New York, N.Y.
,
Jennie Borrelli
1   Clotting Mechanisms Section, Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research, New York, N.Y.
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

Summary

Development of platelet clumps, fusion (VM) and fibrin was studied when an aliquot of platelet-rich plasma (PRP), prepared in siliconed glassware without anticoagulant, was transferred to a glass or siliconed tube and shaken at 37° C.

When PRP was not chilled prior to shaking at 37° C in a siliconed tube, clots rarely formed for 12 minutes. Platelet clumps either developed about 1 minute before the clot or did not form at all. If PRP was chilled before shaking, some samples developed platelet clumps within a minute, long before clotting occurred. Either the platelets in these clumps did not fuse, and the clumps disappeared as the sample became warm, or fusion occurred and the clumps persisted.

The distinction between clumps caused by chilling and those produced just prior to coagulation, presumably by thrombin, was even clearer in PRP from patients with prolonged clotting times caused by AHF, PTC and PTA deficiency than it was in normal PRP. Chilled samples usually developed early clumps even though clotting was delayed. In unchilled samples, clumping was delayed as well as clotting; this was attributed to sluggish thrombin evolution.

When EDTA1 PRP was chilled for several hours and shaken at 37° C in the presence of a physiologic excess of magnesium, clumps formed and the platelets often underwent fusion or VM. No relationship could be found between this type of clumping and the coagulation mechanism, although mercuric chloride and benadryl inhibited both VM produced by cold and that caused by clotting.

* Aided by a grant from the American Heart Association and in part by the U.S. Army Medical Research and Development Command, Dept. of the Army, under contract No. DA-49-007-MD-1013.


 
  • References

  • (1) Lüscher E. F. Viscous metamorphosis of blood platelets and clot retraction. Vox Sang. (Basel) 1: 133 1956;
  • (2) Bounameaux Y. Sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Rev. Hémat. 12: 16 1957;
  • (3) Zucker M. B, Borrelli J. Viscous metamorphosis, clot retraction and other morphologic alterations of blood platelets. J. appl. Physiol. 14: 575 1959;
  • (4) Brinkhous K. M, LeRoy E. C, Cornell W. P, Brown R. C, Hazlehurst J. L, Vennart G. P. Macroscopic studies of platelet agglutination; nature of thrombocyte agglutinating activity of plasma. Proc. Soc. exp. Biol. (N. Y.) 98: 379 1958;
  • (5) Sharp A. A. Viscous metamorphosis of blood platelets: a study of the relationship to coagulation factors and fibrin formation. Brit. J. Haemat. 4: 28 1958;
  • (6) Biggs R, Sharp A. A, Margolis J, Hardisty R. M, Stewart J, Davidson W. M. Defects in the early stages of blood coagulation: a report of four cases. Brit. J. Haemat. 4: 177 1958;
  • (7) Zucker M. B, Borrelli J. Reversible alterations in platelet morphology produced by anticoagulants and by cold. Blood 9: 602 1954;
  • (8) Rosenthal R. L, Dreskin O. H, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc. Soc. exp. Biol. (N.Y.) 82: 171 1955;
  • (9) Hougie C. The activation of platelets by plasma. Rev. beige Path. 24: 141 1955;
  • (10) Mason R. G, LeRoy E. C, Brinkhous K. M. Cation specificity of thrombocyte agglutinating activity (TAg) of canine plasma. Proc. Soc. exp. Biol. (N. Y.) 102: 253 1959;
  • (11) Zucker M. B, Borrelli J. Some effects of divalent cations on the clotting mechanism and the platelets of EDTA blood. J. appl. Physiol. 12: 453 1958;
  • (12) Bergsagel D. E. Viscous metamorphosis of platelets: morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Brit. J. Haemat. 2: 130 1956;
  • (13) Bounameaux Y. Recherches sur le mécanisme de la formation de la thromboplastine sanguine. Acta haemat. (Basel) 17: 65 1957;
  • (14) Øllgaard E. Clot retraction as a quantitative test of the function and agglutinability of the blood platelets. Acta haemat. 6: 220 1951;
  • (15) Fantl P, Ebbels L, Nelson J. F. The presence of thiol groups in thrombocytes and their significance in the contraction of fibrin gel. Brit. J. exp. Path. 32: 538 1951;
  • (16) Bounameaux Y. Antihistaminiques de synthèse et rétraction du caillot. Arch. int. Pharmacodyn. 116: 252 1958;
  • (17) Bounameaux Y. Action des dérivés de la phénothiazine et des antihistaminiques de synthèse sur la morphologie des plaquettes et sur leur adhèsivité “in vitro“. Rev. Hémat. 11: 17 1956;
  • (18) Hugues J. Métamorphose visqueuse des plaquettes et formation du clou hémostatique. Thromb. Diath. haem. 3: 34 1959;
  • (19) Hugues J. Agglutination précoce des plaquettes au cours de la formation du clou hémostatique. Thromb. Diath. haem. 3: 177 1959;